BioQ Pharma Incorporated and Sophos Biotech, both specialty pharmaceutical companies, have entered a strategic partnership agreement in Italy, under which BioQ will supply and Sophos will commercialize a treatment for post-operative pain management.   The 48-hour post-surgical pain management therapy is a disposable, single-use infusion system, which is pre-filled at the point of manufacture with 0.2% Ropivacaine (a non-narcotic local anesthetic). The ready-to-use product is activated by...